{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:36:46Z","timestamp":1795149406895,"version":"4.10.3"},"reference-count":58,"publisher":"American Association for Cancer Research (AACR)","issue":"7","funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["Young Investigator Awards"],"award-info":[{"award-number":["Young Investigator Awards"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["Challenge Awards"],"award-info":[{"award-number":["Challenge Awards"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SPORE program grant","award":["5P50CA272390"],"award-info":[{"award-number":["5P50CA272390"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Tumor-associated macrophages (TAM) are a transcriptionally heterogeneous population, and their abundance and function in prostate cancer is poorly defined. We integrated parallel datasets from single-cell RNA sequencing, spatial transcriptomics, and multiplex immunofluorescence to reveal the dynamics of TAMs in primary and metastatic prostate cancer. Four TAM subpopulations were identified. Notably, one of these TAM subsets was defined by the co-expression of SPP1+ and TREM2+ and was significantly enriched in metastatic tumors. The SPP1+\/TREM2+ TAMs were enriched in the metastatic tumor microenvironment in both human patient samples and murine models of prostate cancer. The abundance of these SPP1+\/TREM2+ macrophages was associated with patient progression-free survival. Spatially, TAMs within prostate cancer bone metastases were highly enriched within the tumor region, consistent with their protumorigenic role. Blocking SPP1 in the RM1 prostate cancer mouse model led to improved efficacy of anti\u2013PD-1 treatment and increased CD8+ T-cell infiltration in tumor. These findings suggest that targeting SPP1+ TAMs may offer a promising therapeutic strategy and potentially enhance the effects of immune checkpoint inhibition in advanced prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Implications:<\/jats:title>\n                    <jats:p>This study expands our understanding of the diverse roles of macrophage populations in prostate cancer metastases and highlights new therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1541-7786.mcr-24-0791","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T12:07:23Z","timestamp":1742386043000},"page":"653-665","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis"],"prefix":"10.1158","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-5898","authenticated-orcid":false,"given":"Shenglin","family":"Mei","sequence":"first","affiliation":[{"name":"1Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia."},{"name":"2Department of Biomedical Sciences and Pathobiology, College of Veterinary Medicine, Virginia Tec, Blacksburg, Virginia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2259-1721","authenticated-orcid":false,"given":"Hanyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts."},{"name":"4Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"8Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9230-1756","authenticated-orcid":false,"given":"Taghreed","family":"Hirz","sequence":"additional","affiliation":[{"name":"3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7904-4747","authenticated-orcid":false,"given":"Nathan Elias","family":"Jeffries","sequence":"additional","affiliation":[{"name":"3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3651-6909","authenticated-orcid":false,"given":"Yanxin","family":"Xu","sequence":"additional","affiliation":[{"name":"3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6054-4163","authenticated-orcid":false,"given":"Ninib","family":"Baryawno","sequence":"additional","affiliation":[{"name":"5Childhood Cancer Research Unit, Department of Women\u2019s and Children\u2019s Health, Karolinska Institutet, Stockholm, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-3700","authenticated-orcid":false,"given":"Shulin","family":"Wu","sequence":"additional","affiliation":[{"name":"6Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0068","authenticated-orcid":false,"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[{"name":"4Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."},{"name":"6Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5306-0208","authenticated-orcid":false,"given":"Akash","family":"Patnaik","sequence":"additional","affiliation":[{"name":"7Section of Hematology\/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4849-3695","authenticated-orcid":false,"given":"Philip J.","family":"Saylor","sequence":"additional","affiliation":[{"name":"8Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9788-0221","authenticated-orcid":false,"given":"David B.","family":"Sykes","sequence":"additional","affiliation":[{"name":"3Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-9627","authenticated-orcid":false,"given":"Douglas M.","family":"Dahl","sequence":"additional","affiliation":[{"name":"4Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"2025070203182409300_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa041318","article-title":"Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer","volume":"351","author":"Petrylak","year":"2004","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"key":"2025070203182409300_bib3","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJMoa1405095","article-title":"Enzalutamide in metastatic prostate cancer before chemotherapy","volume":"371","author":"Beer","year":"2014","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1470-2045(24)00135-9","article-title":"[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial","volume":"25","author":"Emmett","year":"2024","journal-title":"Lancet Oncol"},{"key":"2025070203182409300_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"Parker","year":"2013","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib7","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1056\/NEJMoa2022485","article-title":"Survival with olaparib in metastatic castration-resistant prostate cancer","volume":"383","author":"Hussain","year":"2020","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with standard first-line therapy in metastatic prostate cancer","volume":"381","author":"Davis","year":"2019","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib9","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa2119115","article-title":"Darolutamide and survival in metastatic, hormone-sensitive prostate cancer","volume":"386","author":"Smith","year":"2022","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1200\/JCO.2016.69.1584","article-title":"Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer","volume":"35","author":"Beer","year":"2017","journal-title":"J Clin Oncol"},{"key":"2025070203182409300_bib11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025070203182409300_bib12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/annonc\/mdy232","article-title":"Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study","volume":"29","author":"Hansen","year":"2018","journal-title":"Ann Oncol"},{"key":"2025070203182409300_bib13","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMc1009982","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Tanimoto","year":"2010","journal-title":"N Engl J Med"},{"key":"2025070203182409300_bib14","first-page":"4028","article-title":"Macrophage-derived cholesterol contributes to therapeutic resistance in prostate cancer","volume":"81","author":"El-Kenawi","year":"2021","journal-title":"Cancer Res"},{"key":"2025070203182409300_bib15","doi-asserted-by":"crossref","first-page":"e20221007","DOI":"10.1084\/jem.20221007","article-title":"Macrophages promote anti-androgen resistance in prostate cancer bone disease","volume":"220","author":"Li","year":"2023","journal-title":"J Exp Med"},{"key":"2025070203182409300_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab"},{"key":"2025070203182409300_bib17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"2025070203182409300_bib18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","article-title":"Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses","volume":"14","author":"Hirz","year":"2023","journal-title":"Nat Commun"},{"key":"2025070203182409300_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"2025070203182409300_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat Cell Biol"},{"key":"2025070203182409300_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"2025070203182409300_bib22","doi-asserted-by":"crossref","first-page":"110132","DOI":"10.1016\/j.celrep.2021.110132","article-title":"Resolving the immune landscape of human prostate at a single-cell level in health and cancer","volume":"37","author":"Tuong","year":"2021","journal-title":"Cell Rep"},{"key":"2025070203182409300_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nmeth.3734","article-title":"Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis","volume":"13","author":"Fan","year":"2016","journal-title":"Nat Methods"},{"key":"2025070203182409300_bib24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41592-019-0466-z","article-title":"Joint analysis of heterogeneous single-cell RNA-seq dataset collections","volume":"16","author":"Barkas","year":"2019","journal-title":"Nat Methods"},{"key":"2025070203182409300_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"key":"2025070203182409300_bib26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41586-022-05023-2","article-title":"Spatially resolved clonal copy number alterations in benign and malignant tissue","volume":"608","author":"Erickson","year":"2022","journal-title":"Nature"},{"key":"2025070203182409300_bib27","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2025070203182409300_bib28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"2025070203182409300_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2019.11.014","article-title":"Immune landscape of viral- and carcinogen-driven head and neck cancer","volume":"52","author":"Cillo","year":"2020","journal-title":"Immunity"},{"key":"2025070203182409300_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"key":"2025070203182409300_bib31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"2025070203182409300_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"2025070203182409300_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","article-title":"Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma","volume":"29","author":"Peng","year":"2019","journal-title":"Cell Res"},{"key":"2025070203182409300_bib34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","article-title":"Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia","volume":"37","author":"Witkowski","year":"2020","journal-title":"Cancer Cell"},{"key":"2025070203182409300_bib35","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1038\/s41467-022-33375-w","article-title":"A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma","volume":"13","author":"Alchahin","year":"2022","journal-title":"Nat Commun"},{"key":"2025070203182409300_bib36","doi-asserted-by":"crossref","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"2025070203182409300_bib37","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","article-title":"Macrophage diversity in cancer revisited in the era of single-cell omics","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol"},{"key":"2025070203182409300_bib38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ccell.2024.04.002","article-title":"A temporal perspective for tumor-associated macrophage identities and functions","volume":"42","author":"Bl\u00e9riot","year":"2024","journal-title":"Cancer Cell"},{"key":"2025070203182409300_bib39","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1158\/2159-8290.CD-23-0299","article-title":"Spatial and temporal mapping of breast cancer lung metastases identify TREM2 macrophages as regulators of the metastatic boundary","volume":"13","author":"Yofe","year":"2023","journal-title":"Cancer Discov"},{"key":"2025070203182409300_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-023-01272-6","article-title":"Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions","volume":"16","author":"Mei","year":"2024","journal-title":"Genome Med"},{"key":"2025070203182409300_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"2025070203182409300_bib42","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1007\/s11033-022-07184-9","article-title":"MMP-9 secreted by M2-type macrophages promotes Wilms\u2019 tumour metastasis through the PI3K\/AKT pathway","volume":"49","author":"Tian","year":"2022","journal-title":"Mol Biol Rep"},{"key":"2025070203182409300_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2567.2011.03541.x","article-title":"The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum","volume":"135","author":"Schraufstatter","year":"2012","journal-title":"Immunology"},{"key":"2025070203182409300_bib44","doi-asserted-by":"crossref","first-page":"e001341","DOI":"10.1136\/jitc-2020-001341","article-title":"Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer","volume":"9","author":"Li","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025070203182409300_bib45","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.1073\/pnas.1109402108","article-title":"Sympathetic control of bone mass regulated by osteopontin","volume":"108","author":"Nagao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025070203182409300_bib46","doi-asserted-by":"crossref","first-page":"34758","DOI":"10.18632\/oncotarget.5325","article-title":"CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"key":"2025070203182409300_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","article-title":"CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3","volume":"19","author":"Chen","year":"2011","journal-title":"Cancer Cell"},{"key":"2025070203182409300_bib48","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1038\/s41467-024-49916-4","article-title":"Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome","volume":"15","author":"Guimar\u00e3es","year":"2024","journal-title":"Nat Commun"},{"key":"2025070203182409300_bib49","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","article-title":"EMT, MET, plasticity, and tumor metastasis","volume":"30","author":"Bakir","year":"2020","journal-title":"Trends Cell Biol"},{"key":"2025070203182409300_bib50","doi-asserted-by":"crossref","first-page":"e2102050118","DOI":"10.1073\/pnas.2102050118","article-title":"Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing","volume":"118","author":"Deshmukh","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025070203182409300_bib51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Abeshouse","year":"2015","journal-title":"Cell"},{"key":"2025070203182409300_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"2025070203182409300_bib53","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ucl.2020.10.005","article-title":"The tumor microenvironment and immunotherapy in prostate and bladder cancer","volume":"47","author":"Nair","year":"2020","journal-title":"Urol Clin North Am"},{"key":"2025070203182409300_bib54","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/s41467-018-04724-5","article-title":"Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity","volume":"9","author":"Berglund","year":"2018","journal-title":"Nat Commun"},{"key":"2025070203182409300_bib55","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2025070203182409300_bib56","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"2025070203182409300_bib57","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"2025070203182409300_bib58","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1158\/2159-8290.CD-NB2023-0017","article-title":"PD-1 blockade falls short (repeatedly) in prostate cancer","volume":"13","year":"2023","journal-title":"Cancer Discov"}],"container-title":["Molecular Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/doi\/10.1158\/1541-7786.MCR-24-0791\/3558276\/mcr-24-0791.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/doi\/10.1158\/1541-7786.MCR-24-0791\/3573050\/mcr-24-0791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/23\/7\/653\/3622680\/mcr-24-0791.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/mcr\/article-pdf\/23\/7\/653\/3622680\/mcr-24-0791.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:18:40Z","timestamp":1751426320000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/mcr\/article\/23\/7\/653\/763052\/Single-Cell-and-Spatial-Transcriptomics-Reveal-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,3,19]]},"published-print":{"date-parts":[[2025,7,2]]}},"URL":"https:\/\/doi.org\/10.1158\/1541-7786.mcr-24-0791","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1541-7786.29456870","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456849","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456858","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456846","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456852","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456873","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456861","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456867","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456855","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456843","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456876","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1541-7786.29456864","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1541-7786.c.7906448","asserted-by":"object"}]},"ISSN":["1541-7786","1557-3125"],"issn-type":[{"value":"1541-7786","type":"print"},{"value":"1557-3125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}